Heron Neutron Medical Corp. (TPE:7799)

Taiwan · Delayed Price · Currency is TWD

418.50

+22.50 (5.68%)

At close: Jul 15, 2026

-51.45% (1Y)

Market Cap	65.99B -25.6%
Revenue (ttm)	12.96M +5,561.1%
Net Income	-457.60M
EPS	-3.05
Shares Out	157.68M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	626,665
Open	405.50
Previous Close	396.00
Day's Range	393.00 - 423.00
52-Week Range	300.00 - 984.00
Beta	n/a
Analysts	Strong Buy
Price Target	1,203.33 (+187.53%)
Earnings Date	Jul 24, 2026

About Heron Neutron Medical

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Employees 104

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 7799

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 7799 stock is "Strong Buy." The 12-month stock price target is $1,203, which is an increase of 187.53% from the latest price.

Price Target

$1,203

(187.53% upside)

Analyst Consensus: Strong Buy

Stock Forecasts